Antihypertensive Therapy Recommendations: The Importance of Combinations

This work arises from an initiative committed to analyzing, summarizing, and documenting the latest available scientific evidence in the field of arterial hypertension and the implementation of the best available therapy. Endorsed by the prestigious Central American and Caribbean Society of Cardiology, This text represents the first work of its kind to comprehensively address the issue and topic of arterial hypertension in the region.

Arterial hypertension is a highly prevalent disease worldwide, affecting approximately 1.4 billion people. It is one of the leading causes of cardiovascular morbidity and mortality ¹. It is estimated that by the year 2025, it will affect 1.5 billion people ². Each year, nearly 10 million people lose their lives due to causes attributable to arterial hypertension, primarily related to heart diseases and strokes ³, ⁴. Blood pressure has a direct relationship with the incidence of cardiovascular events, cardiovascular death, atrial fibrillation, chronic kidney disease, cognitive impairment, and other pathologies. Furthermore, it is estimated to be responsible for at least 200 million years of life adjusted for disability ², ³. In this material, you will find a comprehensive compilation of the most up-to-date and evidence-based recommendations for the management of arterial hypertension. You will discover innovative therapeutic strategies and the importance of combinations in controlling this disease.

Do not miss the opportunity to access this invaluable source of knowledge, endorsed by more than six specialists in the field and by the Central American and Caribbean Society of Cardiology. Get your copy of the summary "Anti-Hypertensive Therapy Recommendations: The Importance of Combinations" by downloading the digital edition here!

References:

1. World Health Organization. (2021). Guideline for the pharmacological treatment of hypertension in adults. https://apps.who.int/iris/bitstream/hand le/10665/344424/9789240033986-eng.pdf.

2. Grupo de trabajo de la SEC para la guía ESC/ESH 2018 sobre la hipertensión arterial. Comentarios a la guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial. Rev Esp Cardiol. 2019;72²:104-108. DOI: 10.1016/j.recesp.2018.11.022.

3. Ettehad, D., Emdin, C., Kiran, A., Anderson, S., Callender, T., Emberson, J., et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. 2016;387(10022):957- 967. DOI:10.1016/S0140-6736(15)01225-8.

4. Zhou, B., Carrillo-Larco, R., Danaei, G., Riley, L., Paciorek, C., Stevens, G., et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957-980. DOI:10.1016/S0140-6736(21)01330-1.